Lv2
164 积分 2024-09-01 加入
CAR T cells equipped with a fully human scFv targeting Trop2 can be used to treat pancreatic cancer
1个月前
已完结
CAR T cells equipped with a fully human scFv targeting Trop2 can be used to treat pancreatic cancer
1个月前
已关闭
B cell trajectories influence cancer outcomes
1个月前
已完结
B cells, plasma cells and antibody repertoires in the tumour microenvironment
1个月前
已完结
Interferon-γ predicts the treatment efficiency of immune checkpoint inhibitors in cancer patients
2个月前
已完结
Dual targeting chimeric antigen receptor cells enhance antitumour activity by overcoming T cell exhaustion in pancreatic cancer
5个月前
已完结
IL-2-inducible T cell kinase deficiency sustains chimeric antigen receptor T cell therapy against tumor cells
5个月前
已完结
EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function
5个月前
已完结
A Phase I First-in-Human Clinical Trial of CD19-Targeted 19-28z/4-1BBL "Armored" CAR T Cells in Patients with Relapsed or Refractory NHL and CLL Including Richter's Transformation
5个月前
已完结
Cutaneous T cell lymphoma atlas reveals malignant TH2 cells supported by a B cell-rich tumor microenvironment
5个月前
已完结
皖公网安备34019202002308
